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Abstract
Background Response shift has gained increasing
attention in the measurement of health-related quality
of life (QoL) as it may explain counter-intuitive find-
ings as a result of adaptation to deteriorating health.
Objective To search for response shift type explana-
tions to account for counter-intuitive findings in QoL
measurement.
Methods Qualitative investigation of the response
behaviour of small-cell lung cancer (SCLC) patients
(n = 23) in the measurement of fatigue with The
European Organization for Research and Treatment of
Cancer Core Quality of Life Questionnaire (EORTC
QLQ-C30) question ‘were you tired’. Interviews were
conducted at four points during 1st line chemotherapy:
at the start of chemotherapy, 4 weeks later, at the end
of chemotherapy, and 6 weeks later. Patients were
asked to ‘think aloud’ when filling in the questionnaire.
Results Fifteen patients showed discrepancies be-
tween their answer to the EORTC question ‘were you
tired’ and their level of fatigue spontaneously reported
during the interview. These patients chose the response
options ‘not at all’ or ‘a little’ and explained their an-
swers in various ways. In patients with and without
discrepancies, we found indications of recalibration
response shift (e.g. using a different comparison stan-
dard over time) and of change in perspective (e.g.
change towards a more optimistic perspective). Pa-
tients in the discrepancy group reported spontaneously
how they dealt with diagnosis and treatment, i.e. by
adopting protective and assertive behaviour and by
fighting the stigma. They distanced themselves from
the image of the stereotypical cancer patient and pre-
sented themselves as not suffering and accepting fati-
gue as consequence of treatment.
Conclusion In addition to response shift, this study
suggests that ‘self-presentation’ might be an important
mechanism affecting QoL measurement, particularly
during phases when a new equilibrium needs to be found.
Keywords Small-cell lung cancer  Quality of life 
Response shift  Self-presentation  Fatigue
Introduction
Quality of life (QoL) is considered an important
treatment outcome when the treatment intent is not
curative but palliative. However, the expected deteri-
oration in QoL often does not occur, even in cases of
serious illness. For example, Groen et al. studied pa-
tients with inoperable non-small cell lung cancer trea-
ted by radiation with and without chemotherapy [7].
QoL was measured with The European Organization
for Research and Treatment of Cancer Core Quality of
Life Questionnaire (EORTC QLQ-C30) [1], which has
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been designed specifically for use in clinical trials
focusing on cancer patients. However, contrary to
expectation, they did not find significant deterioration
in the scale scores over the treatment period of
6 weeks. Although cancer patients are willing to un-
dergo risky and toxic treatments [11], it seemed
implausible that the side-effects of treatment had not
affected their QoL. Other studies also reported coun-
ter-intuitive results. For example, patients with a life-
threatening disease or disability were found to report
stable QoL, and patients with a severe chronic illness
reported QoL levels that were not inferior to that of
patients with a less severe illness or to healthy patients
[2, 3, 5]. Such counter-intuitive findings, labelled by
Breetvelt and Van Dam as ‘underreporting of prob-
lems’ suggest that patients report less distress and
dissatisfaction than they actually feel [5].
In recent years, response shift theory has gained
increasing attention in explaining paradoxical and
counter-intuitive findings. Response shift refers to a
change in internal standards, values and conceptuali-
zation of QoL and is recognized as an important
mediator in adaptation to changing health [17]. How-
ever, despite the explanatory power of response shift
theory, our current understanding of phenomena that
can complicate the interpretation of QoL scores is still
limited. Therefore, we investigated QoL measurement
in small-cell lung cancer (SCLC) patients during 1st
line chemotherapy. We were quite surprised when we
noticed discrepancies between levels of fatigue mea-
sured with the questionnaire and answers spontane-
ously reported during the interview. We therefore
investigated these ‘conflicting’ findings in the mea-
surement of QoL in more depth.
This paper reports the results of an exploratory
longitudinal multiple-case study, in which we focused
on how patients responded to the EORTC QLQ-C30
question ‘were you tired’ at different points in their
treatment trajectory. We aimed to describe the pa-
tients’ explanations when answering the question, and
to search for explanations of counter-intuitive findings.
Methods
Procedures and study sample
Between March 2001 and September 2003, we re-
cruited newly-diagnosed patients with SCLC who were
evaluated for 1st line chemotherapy. The patients were
attending one of five outpatient clinics for chest dis-
eases in the Netherlands. To maximize the likelihood
that we would interview patients from the beginning of
their treatment, we were informed about new patients
immediately after diagnosis. No restrictions were made
with regard to age or treatment (chemotherapy or a
combination of chemotherapy and radiotherapy).
Participating patients gave written consent and were
interviewed at equivalent points in the treatment tra-
jectory. The first interview (T1) was carried out at the
start of chemotherapy. In the original plan the second
interview was planned after completion of the course
of chemotherapy. However, after inclusion and first
interviews of 3 patients we made a decision to inter-
view the patients during treatment as well. Therefore
the second interview (T2) was conducted 4 weeks after
T1 and the third (T3) 7–10 days after completion of the
treatment with chemotherapy and the fourth (T4)
6 weeks later. Approval for this study was obtained
from the Medical Ethics Committees of the research
site and the participating hospitals.
During the course of the study, 41 eligible patients
were invited to the study. Four patients were unwilling
to participate, 3 died before informed consent could be
obtained, and 3 were not interviewed because of
imminent death. Of the 31 respondents who were
interviewed, 8 were excluded from further analysis
because their data were incomplete, i.e. they were only
interviewed once (six died within a month after T1 and
two were too sick at T2 and died before the end of the
planned chemotherapy). Consequently, the final study
sample consisted of 23 SCLC patients, of whom 12 had
limited (3 male and 9 female, mean age 55, range 42–
69) and 11 had extended disease (8 male and 3 female,
mean age 64, range 39–72). All patients received
standard chemotherapy, except for 7 patients whose
chemotherapy was combined with local radiation of
the tumour. The majority of the patients were married
(19, 83%), and had children (17, 74%).
Of the 23 patients in our study sample, 15 were
interviewed four times, 7 were interviewed three times,
and one patient was only interviewed twice resulting in
a total of 83 interviews. The interviews were conducted
by MW in the homes of the patients. In three cases the
1st interview was held in the hospital. Interviews
averaged 80–110 min.
Materials and qualitative method
In this exploratory, longitudinal multiple-case study,
QoL was assessed with EORTC QLQ-C30 (version
3.0) [1] and the lung cancer module QLQ-CL13 [4].
The EORTC QLQ-C30 is the most widely used cancer-
specific QoL instrument in European clinical trials.
The questionnaire is composed of several scales, which
measure among others physical function, mental
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health, general health and global QoL. Furthermore, it
measures different symptoms such as pain, dyspnoea,
nausea and fatigue. The Fatigue Scale consists of 3
items: ‘did you need to rest’, ‘have you felt weak’ and
‘were you tired’ (respectively questions 10, 12 and 18),
for which there are 4 response categories: ‘not at all’, ‘a
little’, ‘quite a bit’ and ‘very much’ (respectively scores
1, 2, 3 and 4).
The EORTC QLQ-C30 and CL13 were completed
in combination with the Three-Step Test-Interview
(TSTI) to investigate how respondents interpreted the
items and how they responded to them. The TSTI
consists of the following steps [8]: (1) concurrent think
aloud, aimed at collecting observational data on how a
respondent completes the questionnaire, expressing his
thoughts aloud; (2) focused interview, aimed at clari-
fying respondents’ previous expressions while com-
pleting the questionnaire; (3) semi-structured interview,
aimed at eliciting respondents’ experiences and opin-
ions with regard to the questionnaire.
Interview protocol
Each interview was conducted in an identical format.
At T1, QoL was measured with the EORTC QLQ-
C30, followed by the lung cancer module QLQ-CL13.
The questionnaire was conducted in a concurrent think
aloud manner and after completion, respondents were
asked to clarify previous hesitations, expressions when
rating certain items and experiences (i.e. second and
third step of the TSTI). Individual QoL was then
measured with the Schedule for the Evaluation of
Individual Quality of Life—Direct Weighting (SEI-
QoL-DW) [13, 14]. Finally, we encouraged patients to
talk freely about the impact of diagnosis and treatment.
At follow-up (i.e. T2, T3 and T4), after the SEIQoL-
DW assessment, the EORTC questionnaires were
administered a second time as a so-called ‘then-test’
[15, 16, 18] (i.e. the patients filled out the questionnaire
in reference to how they perceived themselves as they
were in the previous interview). In these 2nd and fol-
lowing interviews, EORTC assessments were con-
ducted in a concurrent think aloud manner and with
the second step of TSTI integrated in the assessment.
In fact, we encouraged patients to think aloud and we
probed for clarification after each item in the case of
extra information was considered useful to understand
patients’ answer. We used a flexible approach in order
not to interrupt the natural flow of both the assessment
as well as the patient-interviewer communication.
The interviews were audio-taped and transcribed
verbatim. In this article we focus on the EORTC QLQ-
C30 question ‘were you tired’.
Analysis
Three types of data were collected and used for analysis
[12]: (1) completed EORTC questionnaires (T1–T4),
(2) observed respondent behaviour recorded in field
notes, and (3) transcriptions of the interviews, including
‘think aloud’. The analysis was aimed at identifying
discrepancies, response strategies and explanations of
response behaviour. We used the qualitative computer
package Kwalitan 5.0 (http://www.kwalitan.net) to ex-
tract relevant parts of the transcriptions (1) ‘think
aloud’ of the question ‘were you tired’ and of other
items that were useful in understanding the response
behaviour to the question on fatigue (i.e. two other
items of the fatigue scale, the general health and the
global QoL question of the QLQ-C30), and (2) ‘com-
ments’ related to fatigue symptoms, impact of treat-
ment on perceived QoL, and attitudes towards life. In
order to deal with the still remaining large amount of
extracted data, two of the authors (MW, AT) con-
densed extracted transcripts of the ‘comments’ into
core texts. For each patient, the data (i.e. think aloud
combined with scores and core texts of comments) were
organized per interview in one mind map (see example
in Fig. 1) by means of the computer package Mindjet
Mindmanager Pro 6 (http://www.mindjet.com).
Furthermore, a different mind map was made to
organize think aloud data related to the question ‘were
you tired’ for all patients per response category per
assessment, including then-test. For the analysis, three
authors (MW, AT, TH) each independently read the
mind maps of each patient. They studied patients’
scores, their think aloud responses, and examined
whether response shift type explanations would be
provided: recalibration (i.e., using different standards
of comparison to assess fatigue over time), reprioriti-
zation (i.e., changes in the importance attached to fa-
tigue over time) and reconceptualization (i.e., changes
in the meaning of fatigue over time). Two researchers
(MW, AT) searched for additional explanations in the
core texts to account for the response behaviour and
the discrepancies. The research team (MW, AT, TH,
MS) discussed critically the different response strate-
gies used by the patients and the robustness of the
interpretations of response shift.
Results
Patients with or without discrepancies
Of the 23 patients, 15 (5 male and 10 female, age 46–
72) showed discrepancies at least at one measurement
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point, i.e. differences between their answer to the
EORTC question ‘were you tired’ and their level of
fatigue spontaneously reported during the interview. In
their answers to the EORTC questionnaire they all
presented themselves positively and said that they
were not tired. Mary, for example, was 60 years old at
the time of the first interview. During all her interviews
she reported that she was tired, but she consistently
answered ‘not at all’ to the EORTC question (Box 1).
Only once she scored ‘a little bit’. This was at T2 when
filling in her questionnaire as a then-test for T1 and she
commented ‘‘a little, more than at the moment’’.
Box 1 Example of a patient with discrepancies in reported level
of fatigue
Patient Mary
Mary was 60 years old and married. She had two sons and two
grandchildren. Her answer to the EORTC question was
consistently ‘not at all’, except for the then-test concerning the
interview T1. This suggests that she did not suffer from fatigue in
the week prior to the interviews and that fatigue due to
chemotherapy did not have any impact at all on her energy level.
But, during the interview she spontaneously provided information
that indicated that chemotherapy had an impact on her life and
that she regularly suffered from fatigue.
T1 EORTC score ‘not at all’
Think aloud: Were you tired... no not at all, no, no difference
compared to the past
Interview: I’m getting tired at the least little thing
For many of our respondents, every new cycle of
chemotherapy had a more severe impact on their en-
ergy level. Therefore, the highest level of fatigue was to
be expected after the 5th and last cycle of chemo-
therapy, at T3. However, the 15 patients with dis-
crepancies all answered the question ‘were you tired’
with ‘not at all’ or ‘a little’. For example, during her
Fig. 1 Analysis by means of a
mind map. Branch EORTC:
scores of GH/QOL and the
fatigue scale are organized
per interview and
complemented by the think
aloud data. Branch
Comments: core texts of
relevant parts of transcripts
are organized per code and
per interview. Note: (+) not
all branches of the different
interview moments are shown
Box 1 continued
T2 EORTC score ‘not at all’
Think aloud T2: Not tired, last week, not at all
Think aloud then-test T1: a little, more than at the moment.
Interview: According to the doctors, the X-rays were very
good. I’m very optimistic, sometimes I’m tired but that’s my
own fault. I don’t have as much energy as I did before I
became ill.
T3 EORTC score ‘not at all’
Think aloud: Last week I wasn’t tired, it’s the second week after
my chemo, not at all tired
Think aloud then-test for T2:not at all
Interview: Yes, it was my last cycle of the chemo, I was afraid
that I wasn’t going to be able to carry on through the
treatment. But I managed, okay; I’m tired but apart from that...
nothing at all.
T4 EORTC score ‘not at all’
Think aloud: No I wasn’t tired last week, not at all
Think aloud then-test for T3:not at all
Interview: Now and then, I’m tired. It’s different to before my
chemotherapy. Sometimes I’m so tired, so tired, more than in the
past. It comes suddenly...in the middle of the day.
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interviews at T2 and T3, Ann reported the growing
impact of every cycle of chemotherapy, but her answer
to the EORTC question at both interviews was ‘a little’
(Box 2).
Box 2 Example of a patient using different response strategies,
comparison with more sick patients, response shift and self-
presentation
Patient Ann
Ann was 47 years old and living with a partner. She didn’t have
any children.
Her scores suggest that the chemotherapy had a slight impact on
her energy level during her treatment and a greater impact 6 weeks
after completion of the treatment. But, the interview and the think
aloud provided information that indicated that the chemotherapy
had a growing impact on her life, and the score ‘quite a bit’ at T4
was the result of bad news (i.e. a recurrence of the tumour).
Furthermore, her data show examples of different response
strategies, comparison with more sick patients and self-
presentation.
T1 EORTC score ‘not at all’
Think aloud: Were you tired.. in principle I wasn’t tired. I was
mentally tired, it costs me a lot of energy to talk with my
relatives. I think you mean physically tired. You’re tired in the
sense that you can hardly put one foot in front of the other.
That’s being tired. No I’m not tired.
Interview: I want to be realistic, think positively. I try not to
worry; there is nothing I can do. I don’t know when I will die. I
get angry when people are surprised...if I say I’m doing fine...it’s
my decision how I’m feeling.
T2 EORTC score ‘a little bit’
Think aloud: I feel it a little bit, compared to other people who
are very sick. So, if I have pain or when I’m tired I say to myself
don’t complain, so everything I feel, I only feel a little. I’m doing
fine.
Think aloud then-test for T1:a little
Interview: Yesterday, I worked for three hours and I was
exhausted. I went to bed in the middle of the day in order to be
able to show my friend that I’m doing fine. She has trouble in
coping...me... having cancer.
T3 EORTC score ‘a little bit’
Think aloud:A little, yes because I have the feeling that I was
able to get over it
Think aloud then-test for T2: I think that I’ve said a little last
time, it felt a little, but I shift my limit.
Interview: It’s a kind of tiredness, I don’t know. I’ve never been
like that. To allow yourself to be tired. I think that the story they
all tell, that the last cycle of chemo has the most impact, I think
that’s very very true.
T4 EORTC score ‘quite a bit’
Think aloud: Yes, I was quite a bit tired, but only mentally tired.
I have to adjust to the idea of a new course of treatment and
radiation. My health is excellent. I’m able to do everything I like,
better than 6 weeks ago. But, with all the medicine I’m taking to
suppress the epileptic fits... I’m scared, just like after the start of
chemo.
Think aloud then-test for T3:a little but I am not really sure, the
pain which I had in my ankels made me tired.
Interview: The radiation will make me tired, but it has not started
yet, so I am not tired yet.
Patients with discrepancies were identified in both
stages of disease and with both treatment regimens, i.e.
12 patients (LD n = 5, ED n = 7) treated with
chemotherapy and 3 LD patients treated with chemo-
therapy and radiotherapy. During the course of the
treatment (T1–T4, 55 interviews) they answered the
question ‘‘were you tired’’ 20 times with ‘not at all,
29 times with ‘a little’, 4 times with ‘quite a bit’ and
twice with ‘very much’ (see individual scores per
interview in Table 1)
No discrepancies were identified in 8 of the 23 pa-
tients (LD n = 4, ED n = 4, age 39–72). They answered
the question ‘were you tired’ at the end of chemo-
therapy (T3) with ‘quite a bit’ or ‘very much’. During
the course of treatment (T1–T4, 28 interviews) these
patients answered the question twice with ‘not at all’,
9 times with ‘a little’, 11 times with ‘quite a bit’ and
6 times with ‘very much’ (Table 1).
Then-test scores were dissimilar with scores of the
previous assessment in 25 out of 52 cases, with higher
then-test scores in 16 cases. Transcripts showed that
patients had difficulty remembering either the previous
measurement point and/or their fatigue at that time.
Response strategies for the four response options
The think aloud texts for the response categories ‘quite
a bit’ and ‘very much’ were minimal in the entire study
population. Only a few patients reacted briefly during
the think aloud, e.g. ‘‘quite a bit, too tired to keep my
eyes open’’, ‘‘yes quite a bit, very tired’’ and ‘‘next week
it will be better...very much’’. The same pattern was
found in all patients for all four response options when
filling in the questionnaire as a then-test, e.g. ‘‘a little
bit, I think’’, ‘‘tired then, no’’ and ‘‘very much’’. How-
ever, patients in the group with discrepancies had much
more to say in the conventional QoL measurement
when choosing the options ‘not at all’ and ‘a little’.
During ‘think aloud’, they seemed to justify the chosen
response category. They used various strategies to
moderate the impact of fatigue on their life. We sum-
marized their strategies in four categories: (1) I am not
tired all the time (e.g. ‘‘only in the afternoon’’); (2) I am
not really tired, it’s something else (e.g. ‘‘ it’s the flu’’);
(3) I have no problems with it (e.g. ‘‘I can still cope with
it; I don’t want to exaggerate’’); (4) I am a little bit tired
but it is due to something else (e.g. ‘‘I didn’t have a
proper meal’’).
Many of our respondents said that they had ex-
pected to become very tired as a result of the treat-
ment, but that they were not as sick as they had
expected. They were very happy that they were able to
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cope with the treatment, and had adjusted to the sit-
uation. A male patient, for example, had a score of ‘not
at all’ at T2, and explained: ‘‘I’m currently doing
nothing, so I’m not tired’’. The respondents indicated
that they wanted to be honest when filling in the
questionnaire and did not want to lie or to exaggerate
their fatigue and, because many patients were not tired
all the time they considered a score of ‘not at all’ or ‘a
little’ to be a suitable score (Box 3).
Box 3 Examples of different response strategies used by pa-
tients with discrepancies (n = 15)
Think aloud about the question ‘were you tired’
I’m not tired all the time
I’m only tired in the afternoon
No not at all, I’m not tired at the moment, it comes suddenly
I have to be honest, sometimes I’m tired, I can’t say not at all,
otherwise I would be lying
I’m not really tired, it’s something else
No not tired, it’s the flue, that’s why I’m tired
It’s not being tired you know, it’s more like being restless
I’m not physically tired, I’m mentally tired
Optimism
Most patients told the interviewer regularly that they
had adapted to the situation and had changed their
attitude towards a more optimistic perspective. They
were not hopeful immediately after diagnosis, but
optimism about recovery increased when the tumour
was shrinking. Of the 23 patients 17 reported sponta-
Table 1 Individual (then-test) scores of patients answering the
EORTC QLQ-C30 question ‘were you tired’. Response catego-
ries 1, 2, 3 and 4 are representing respectively the category ‘not at
all’, ‘a little’, ‘quite a bit’ and ‘very much’. Small-cell lung cancer
patients (n = 23), limited (LD) and extended (ED) disease
receiving 1st line chemotherapy were interviewed at equivalent
points in treatment: at start of chemotherapy (T1), 4 weeks later
(T2), at end of chemotherapy (T3), and 6 weeks later (T4). T1t,
T2t and T3t are representing then-test scores obtained at
respectively T2, T3 and T4, when patients are asked to provide
a renewed evaluation of their fatigue at the previous assessment.
Two groups were identified: patients with (n = 15) and without
(n = 8) discrepancies between their questionnaire answer and
fatigue spontaneously reported in the interview
Patients’ characteristics
Nr. M/F Age LD/ED T1 T1t T2 T2t T3 T3t T4
Discrepancies
P 02 Male 57 ED 3 3 – – 1 – –
P 04 Female 50 LD 1 2 2 3 2 3 2
P 08 Female 69 ED 2 2 1 2 1 2 2
P 09 Male 66 ED 3 2 2 2 2 2 2
P 10 Male 46 LD 2 2 2 2 2 2 2
P 12 Female 47 LD 1 2 2 2 2 2 3
P 15 Female 69 LD 1 2 2 3 2 3 2
P 17 Female 64 ED 2 2 2 2 2 – –
P 18 Male 72 ED 1 1 2 – 1 – 3
P 21 Male 69 ED 2 2 2 3 2 2 2
P 22 Male 55 LD 4 1 1 – 2 – –
P 24 Female 56 LD 1 1 1 2 1 2 1
P 26 Female 59 LD 4 2 1 2 2 – –
P 32 Female 60 LD 1 2 1 1 1 1 1
P 34 Female 51 LD 1 1 2 1 2 1 1
No discrepancies
P 01 Female 42 LD 2 2 – – 4 4 3
P 03 Female 64 ED 3 1 – – 3 3 4
P 13 Male 72 ED 3 3 2 3 3 2
P 14 Male 39 LD 4 3 2 2 3 – –
P 16 Male 68 LD 1 1 3 3 3 3 2
P 20 Female 44 LD 1 – 4 – 4 – 4
P 27 Male 69 LD 3 2 2 – – 4 2
P 29 Male 63 ED 2 3 3 2 3 3 2
Box 3 continued
Actually, I can’t be tired because the Hb level in my blood is
okay
I’ve no problems with it
I’m currently doing nothing, so I’ve no problems, I’m not tired
Of course, you can make yourself tired, but I’ don’t
I can still cope with it; I don’t want to exaggerate
I’m a little bit tired but it’s due to something else
A little, but it was my own fault, I did too much
I didn’t have a proper meal, that’s why I was tired
I didn’t have my lady working for me in the house, she went on
holiday
It’s because I’ve got problems with my voice caused by the
radiation
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neously that they were optimistic: e.g. ‘‘I’ve got good
news, I’m as optimistic as can be’’, ‘‘I’m full of hope
because I was diagnosed in an early stage, so I’m good
in time’’. Furthermore, they said that they felt better
off than expected, compared to patients who were
worse off: e.g. ‘‘I’m lucky not to be very sick, compared
to the patients I saw at the hospital’’. Although they
experienced the impact of every new cycle of treatment
as more severe, they said to be able to cope with the
treatment and to accept the side-effects: e.g. ‘‘it’s part
of the package, I’m willing to put up with, knowing the
chemo is doing the job properly’’. Some patients were
actually feeling better after each cycle and happy that
they were still alive: e.g. ‘‘It was much worse than I
wanted to admit last time, I’m feeling much better’’,
‘‘I’ve already a couple of months extra’’.
In contrast, 5 of the 23 patients expressed pessimistic
feelings: e.g. ‘‘I’m a broken man, hard work all my life
and now...I don’t think I’ve much time left’’, ‘‘I’m a bit
depressed, when does it stop, if it doesn’t stop it would
be better if my life was over’’, ‘‘No plans for the future,
you never know when the tumour will come back’’.
These patients all reported high levels of fatigue during
the course of the treatment. One patient did not pro-
vide specific comments about optimism or pessimism.
Response shift and self presentation
In both groups—with and without discrepancies—we
found patients who had reported to have changed their
reference point after T1 (i.e. recalibration in contrast
to T1). They compared their fatigue at the second and
following interviews with that of other patients e.g. ‘‘I
was tired, yes, but compared to the patients I’ve seen in
the hospital, I’m just a little bit tired’’ or, with the period
in which they were more tired (e.g. ‘‘Compared to the
first week after chemo, it’s the second now ... I’m not
tired’’). In one case, a patient spontaneously re-evalu-
ated her previous measurement: ‘‘I told you that I was
really tired then, but compared to how I’m feeling now,
it was then just a piece of a cake’’. Another one spoke
about a shift of limits which also suggests recalibration:
‘‘I already told you that I would change my standards’’.
We did not find indications of reconceptualization
and reprioritization of fatigue. The only exception was
Ann who made a distinction between being physically
and mentally tired (see Box 2). At T1, she said that she
was mentally tired but not physically and her answer
was ‘not at all’: ‘‘Tired means that you can hardly put
one foot in front of the other’’. At T4, she said that she
had recovered from chemotherapy and was physically
able to do anything she wanted but, unfortunately,
suffered from sudden epileptic attacks caused by
metastases. She was feeling anxious in the same way as
at the start of her chemotherapy, and had to consider
further treatment options. Just like in the interview at
T1, she said that she was mentally tired but not phys-
ically. However, this time her score was ‘quite a bit’
instead of ‘not at all’: ‘‘Purely, because I was mentally
tired last week. I have to adjust to the idea of a new
course of treatment. Actually, I have to admit that I
really am the cancer patient I never wanted to be’’. This
response pattern might be interpreted as reprioritiza-
tion (i.e., changes in the importance attached to mental
fatigue over time).
Box 4 Examples of coping strategies used by patients with dis-
crepancies (n = 15)
Spontaneously reported coping behaviour
Protective behaviour
I’m trying to avoid or minimize pessimistic thoughts
I don’t think about it, otherwise I can’t cope with it
We don’t talk about it, just follow my every day routine
I’m building a wall around myself
Assertive behaviour/power display
I’ll show others that I’m managing all right
You have to be positive
You have to believe in yourself, otherwise you can’t manage it
anymore
Fighting the stigma
I’m not the cancer patient my neighbour thinks I am
They think I’m lying on my bed all day
People look at me, and give advice that I don’t want
I have to admit that I really am a cancer patient... I didn’t want to
be (see patient Ann, Box 2).
Because the above mentioned response shift type
explanations could not adequately explain our con-
flicting findings in the discrepancy group we ques-
tioned: ‘‘Why are patients presenting themselves in the
questionnaire more positively than in the informal
interview’’. In our search for an other explanation, we
found that 13 of the 15 patients with discrepancies had
spontaneously reported how they dealt with having
cancer and the perspective of a short life-expectancy.
We summarized their comments in three categories
(see examples of coping strategies in Box 4): (1) Pro-
tective behaviour (e.g. protecting themselves from
harmful thoughts); (2) Assertive behaviour/power dis-
play (e.g. projecting the image of being positive and
managing all right); (3) Fighting the stigma (e.g. fight-
ing against being stigmatized).
Taking these strategies into account, we concluded
that a possible mechanism underlying the discrepancies
in this group was ‘self-presentation’. As the question-
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naires are explicitly related to cancer and since these
patients want to distance themselves from being re-
duced to only a cancer patient, they want to present
themselves as a person who just happened to have
cancer. Therefore, they applied various strategies to
respond to the question on fatigue in order to produce a
score that was as favourable as possible and presented
themselves as positive and managing their fatigue.
Discussion
Two third of the patients showed discrepancies in their
reported level of fatigue. They reported a gradual de-
crease in energy at the end of chemotherapy, but they
were ‘not at all’ or just ‘a little bit’ tired according to
their answer to the EORTC questionnaire, with und-
erreporting as a result. They presented a positive image
of themselves and used various strategies to explain
their choice of response category. A predominant
finding was that patients adopted a more optimistic
perspective on the treatment. Interestingly, this was
not exclusively found in the discrepancy group. The
same was true for recalibration and for the only indi-
cation of reprioritization. These response shift type
explanations did not sufficiently account for the con-
flicting findings in our discrepancy group.
Self-presentation was found to be an additional
(coping) mechanism underlying the discrepancies. Our
results suggest that patients are not only concerned
about the impression they make on others. They try to
protect themselves from negative thoughts and they
also feel the need to be positive and to distance
themselves from the stereotypical cancer patient. With
this strategy they are more capable of coping with a
situation that they cannot change.
The suggestion that self-presentation is an underly-
ing mechanism is supported, for example in the case of
Ann. After a recurrence of the tumour she adopted the
realistic perspective by admitting that she really was
‘the cancer patient’, which she did not want to be be-
fore. It seems that she had given up her attitude of
showing others that everything was all right, and for
the first time she did not present her self as more po-
sitive than she actually was as she did before.
Self-presentation (also called impression manage-
ment [6, 9]) is a phenomenon described by Leary et al.
in relation to health behaviour [10]. They discussed its
implications for research in health psychology. Our
study shows that, in addition to response shift, self-
presentation may explain unexpected results, at least in
SCLC patients. The question ‘were you tired’ in the
EORTC-QLQ-C30 does not unequivocally measure
the impact of chemotherapy on the energy level of
patients; in fact, with their responses, patients seem to
show how that they are managing the situation. From
our results we cannot conclude that in the group
without discrepancies self-presentation is not present
at all, or that whenever self-presentation occurs dis-
crepancies will also be present. However, our study
does show that self-presentation affects QoL mea-
surement. These findings must be taken into account
when investigating and interpreting QoL data, also in
other study populations. Especially after diagnosis and
in the initial phase of treatment, self-presentation
might be an important coping strategy. In fact, during
each phase in which a new equilibrium and a new
identity has to be found (e.g. after a recurrence of the
tumour, or metastases) self-presentation might affect
QoL measurement.
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